Technology Enablement Medical Information Services

ProPharma’s Technology Enabled MI Expertise

In Medical information, we are integrating advanced technological tools such as AI to enhance the efficiency and quality of our services. Our approach is to embed the technologies in our workflow for patients and healthcare providers to reach us quicker and our team to provide the needed information promptly with a higher quality of service. AI can be part of our workflow from triaging, content search, response generation, quality control, and analytics.

We adopt the co-pilot concept where AI assists our MI specialists to be more efficient and MI specialists meticulously review AI’s work for accuracy, completeness, and compliance before delivering to patients and healthcare providers. This synergistic approach not only accelerates response times and improves service quality but also fosters a collaborative environment where human expertise and AI capabilities complement each other effectively. As we continue to evolve with technological advancements, we are committed in providing reliable medical information services.

Hand holding pen between fingers typing on laptop and using tablet device

AI Technology Use in Medical Information Services

Illustration of how ProPharma's Tech Enablement capabilities serve specific needs
Product compliant intake icon

Natural Language Processing (NLP)

Natural Language Processing (NLP)

Medical Information icon

Advanced Search Engine for Contents

Advanced Search Engine for Contents

Innovation icon

Generative AIs for Response Delivery

Generative AIs for Response Delivery

Adverse event intake icon

Enhanced Quality Control and Analytics

Enhanced Quality Control and Analytics

Natural Language Processing (NLP)

As a contact center, NLP can be implemented throughout the MI workflow. Voice recognition can be used in incoming calls for faster triage compared to selecting menu options for patients, their caregivers, and healthcare providers. IVR messages or automatic responses can be recorded with an AI voice generator in seconds with over 50 languages and various voice options. Additionally, a voice generator is a great tool to leverage how to pronounce certain medical terminology or non-native language vocabulary.

Although we pride ourselves in our services with more than 35 native-speaking professional specialists, AI translation allows us to cover more languages and reach additional countries This enables us to extend access to medical information to smaller markets previously underserved. Non-native speakers can assist inquiries in other languages if unexpected volume increases are occurring in different regions. The combination of AI translation and voice generation, validated for accuracy and quality, can produce a verbal response by non-native or non-proficient speakers. This ensures the timely delivery of responses to patients and healthcare providers during periods of unusually high inquiry volume.

Row of customer service professionals wearing headset one person smiling at camera

Advanced Search Engine for Contents

In the MI workflow, keywords are used to find documents that contain appropriate responses to inquiries. Most database keyword search is based on exact spell matching, and the correct documents may not be retrieved with misspelling or non-matching terminology. Advanced search engines, however, can recognize and correct misspellings and fetch documents that not only match the keyword but also the synonyms. For example, when the specialists search for ingredients, and AI enabled process searches for formulation, excipients, components, and such. This increases efficiency in the workflow by reducing the need to repeat searches with multiple keywords, ultimately delivering the MI response quickly for our patient care decision.

Person working on desktop and laptop devices

Generative AIs for Response Delivery

Generative AI is a powerful tool and can aid our specialists in generating MI responses, documents, and patient materials. AI scans and reviews large datasets and literature, extracting relevant information in a matter of seconds and summarizing it for specialists or medical writers to evaluate and edit. It also converts documents from one format into another such as adapting external documents to internal templates with translation. AI is consistent with terminology, style, and formatting throughout the document and across the same type of documents and can be trained to adhere to compliance requirements. This significantly reduces the time for specialists and medical writers to research the databases and draft documents from the blank, delivering the necessary information for therapy decisions faster for healthcare providers.

Professional workers collaborating in an office

Enhanced Quality Control and Analytics

Real-time transcription (speech-to-text) tremendously augments the efficiency and quality of various parts of the MI workflow. AI can analyze real-time conversations to support specialists in locating the relevant documents for response and suggest conversational advice based on the customer's intent and sentiment. Additionally, AI can detect adverse events (AEs) or product quality complaints (PQCs) within a conversation to prompt the specialist to take appropriate action. This ability directly applies to the quality control process, where both verbal and written inquiries are scanned for accuracy, completeness, AE and PQC intake, soft skill, and other specific components, which improves the performance and quality of MI teams.

The transcription is a source document that contains the entire conversation. It is impractical to listen to all calls, but with transcription, we can see all calls and have a much bigger and richer pool of data. This means better representation of the population, reduced biases, and more detailed analysis that could provide valuable insights that could aid business decisions for patient care.

Business professionals smiling at a desk reviewing data
Gradient Image

Experience the Future of Medical Information Services

Our technology-enabled approach ensures rapid, accurate, and high-quality responses for patients and healthcare providers. Partner with ProPharma and experience the synergy of AI and human expertise today.

Technology Enablement Experts

  • Rajul Jain Bio Photo

    Rajul Jain

    President, Medical Information

    View Bio

  • Emily Bevington Bio Photo

    Emily Bevington

    Associate Director, Global Innovation and Implementation

    View Bio

  • Valerie Huh Bio Photo

    Valerie Huh

    Director, Global Innovation and Implementation

    View Bio

Rajul Jain has over 19 years of international experience in Medical Information (MI), Pharmacovigilance (PV), Technology, and Program Management. With an extensive educational background including an MBA, Engineering degree, PMP, Medical Affairs Competency Certificate (ACMA), and various other healthcare certifications, she brings a wealth of knowledge to her roles. She is currently President of Medical Information in ProPharma with responsibility for oversight and expansion of global contact center operations. Prior to this, she managed all of the MI programs for IQVIA and technology and automation solutions for MI/PV programs. Rajul is passionate about improving business processes and fostering innovative solutions in the healthcare and pharmaceutical industry.

Emily Bevington has 9 years of experience in Medical Information Operations and Program and Project Management. She has studied BSc Biological Sciences and MSc Artificial Intelligence. With a background in technology and programming, she is competent in the design, development and deployment of technology solutions, with a particular focus on Data Science, Artificial Intelligence and Machine Learning.

Valerie Huh brings over 20 years of experience in the pharmaceutical and healthcare industries, with expertise in global operations and process improvements. She holds a Doctor of Pharmacy (Pharm.D.), a degree in Chemistry, and an MBA with a certificate in business analytics. In her current role, she leads innovation and technology enablement in Medical Information and supports business expansions, driving forward strategic initiatives to enhance service quality and operational efficiency.

News & Insights

Patient Support Programs in India: Overcoming Barriers with Healthcare Access

November 19, 2024

Patient Support Programs in India: Overcoming Barriers with Healthcare Access

Explore India's healthcare challenges, including affordability, rural access issues, and the role of Patient Support Programs in improving medication access.

Checklist for Building a Successful Risk Evaluation and Mitigation Strategy (REMS) Program

November 18, 2024

Checklist for Building a Successful Risk Evaluation and Mitigation Strategy (REMS) Program

Build a successful Risk Evaluation and Mitigation Strategy (REMS) program to ensure drug safety and regulatory compliance with our comprehensive checklist.

Meet the Expert: Andrew Bright

November 14, 2024

Meet the Expert: Andrew Bright

Discover how Andrew Bright, Senior Consultant, Product Lifecycle Management at ProPharma, manages complex manufacturing and transfer projects

ProPharma Appoints Brian Tuttle as Chief Financial Officer

October 21, 2024

ProPharma Appoints Brian Tuttle as Chief Financial Officer

ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Names Dawn Sherman Chief Executive Officer

September 30, 2024

ProPharma Names Dawn Sherman Chief Executive Officer

Dawn Sherman rejoins ProPharma as CEO, bringing nearly 30 years of industry experience to lead the regulatory, clinical, and compliance services provider.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

ProPharma Receives 2024 CRO Leadership Award

June 13, 2024

ProPharma Receives 2024 CRO Leadership Award

ProPharma wins 2024 CRO Leadership Award for exceeding expectations in key categories, solidifying its position as a top global research consulting organization in the life sciences industry.

Infographic The Cost of Poor Project Management - ProPharma

June 10, 2022

The Cost of Poor Project Management

Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...

Infographic Successfully Passing MHRA Inspections for Overseas Manufacturing Sites - ProPharma

August 31, 2022

Successfully Passing MHRA Inspections for Overseas Manufacturing Sites

ProPharma offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. ProPharma’s Compliance and Quality team completed the first on-site...

Infographic Navigating the Generic Drug Application and Approval Process - ProPharma

October 4, 2021

Navigating the Generic Drug Application and Approval Process

Navigating the generic drug application and approval process can be challenging. From pre-filing through post-approval, find out exactly what needs to be done for your Abbreviated New Drug...

News & Insights

ProPharma Appoints Brian Tuttle as Chief Financial Officer

October 21, 2024

ProPharma Appoints Brian Tuttle as Chief Financial Officer

ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Names Dawn Sherman Chief Executive Officer

September 30, 2024

ProPharma Names Dawn Sherman Chief Executive Officer

Dawn Sherman rejoins ProPharma as CEO, bringing nearly 30 years of industry experience to lead the regulatory, clinical, and compliance services provider.

Previous Post Arrow Next Post Arrow
ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

ProPharma Receives 2024 CRO Leadership Award

June 13, 2024

ProPharma Receives 2024 CRO Leadership Award

ProPharma wins 2024 CRO Leadership Award for exceeding expectations in key categories, solidifying its position as a top global research consulting organization in the life sciences industry.

Previous Award Arrow Next Award Arrow
Patient Support Programs in India: Overcoming Barriers with Healthcare Access

November 19, 2024

Patient Support Programs in India: Overcoming Barriers with Healthcare Access

Explore India's healthcare challenges, including affordability, rural access issues, and the role of Patient Support Programs in improving medication access.

Checklist for Building a Successful Risk Evaluation and Mitigation Strategy (REMS) Program

November 18, 2024

Checklist for Building a Successful Risk Evaluation and Mitigation Strategy (REMS) Program

Build a successful Risk Evaluation and Mitigation Strategy (REMS) program to ensure drug safety and regulatory compliance with our comprehensive checklist.

Meet the Expert: Andrew Bright

November 14, 2024

Meet the Expert: Andrew Bright

Discover how Andrew Bright, Senior Consultant, Product Lifecycle Management at ProPharma, manages complex manufacturing and transfer projects

Previous Post Arrow Next Post Arrow
Infographic The Cost of Poor Project Management - ProPharma

June 10, 2022

The Cost of Poor Project Management

Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...

Infographic Successfully Passing MHRA Inspections for Overseas Manufacturing Sites - ProPharma

August 31, 2022

Successfully Passing MHRA Inspections for Overseas Manufacturing Sites

ProPharma offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. ProPharma’s Compliance and Quality team completed the first on-site...

Infographic Navigating the Generic Drug Application and Approval Process - ProPharma

October 4, 2021

Navigating the Generic Drug Application and Approval Process

Navigating the generic drug application and approval process can be challenging. From pre-filing through post-approval, find out exactly what needs to be done for your Abbreviated New Drug...

Previous Resource Arrow Next Resource Arrow